Indication
Gastrointestinal stromal tumor
A gastrointestinal stromal tumor is a rare mesenchymal neoplasm of the digestive tract that originates from the interstitial cells of Cajal or their precursors, which function as pacemaker cells regulating gastrointestinal motility. Read more about Gastrointestinal stromal tumor
11 drugs 11 manufacturers
Drugs that treat it
Common Gastrointestinal stromal tumor therapies.
SUNITINIB MALATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA gastrointestinal stromal tumor is a rare mesenchymal neoplasm of the digestive tract that originates from the interstitial cells of Cajal or their precursors, which function as pacemaker cells regulating gastrointestinal motility.
Although it can develop anywhere along the alimentary canal, it most commonly arises in the stomach and small intestine, predominantly affecting older adults.
Pathophysiologically, most cases are characterized by mutually exclusive gain-of-function mutations in the *KIT* or *PDGFRA* receptor tyrosine kinase genes, with a small subset driven by succinate dehydrogenase deficiency or other alterations.
Behavior ranges from indolent, small nodules to aggressive, highly metastatic sarcomas typically spreading to the liver and peritoneum.
- nih.gov
A gastrointestinal stromal tumor is a rare mesenchymal neoplasm of the digestive tract that originates from the interstitial cells of Cajal or their precursors, which function as pacemaker cells regulating gastrointestinal motility Although it can develop anywhere along the alimentary canal, it most commonly arises in the stomach and small intestine, predominantly affecting older adults Behavior ranges from indolent, small nodules to aggressive, highly metastatic sarcomas typically spreading to ...
- nih.gov
A gastrointestinal stromal tumor is a rare mesenchymal neoplasm of the digestive tract that originates from the interstitial cells of Cajal or their precursors, which function as pacemaker cells regulating gastrointestinal motility Pathophysiologically, most cases are characterized by mutually exclusive gain-of-function mutations in the *KIT* or *PDGFRA* receptor tyrosine kinase genes, with a small subset driven by succinate dehydrogenase deficiency or other alterations
- mypathologyreport.ca
Pathophysiologically, most cases are characterized by mutually exclusive gain-of-function mutations in the *KIT* or *PDGFRA* receptor tyrosine kinase genes, with a small subset driven by succinate dehydrogenase deficiency or other alterations
- cancer.gov
Behavior ranges from indolent, small nodules to aggressive, highly metastatic sarcomas typically spreading to the liver and peritoneum
Personalize your experience
Follow Gastrointestinal stromal tumor and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.